04:55 PM EDT, 06/10/2026 (MT Newswires) -- Nyxoah ( NYXH ) secured $110 million in new capital to support the US commercial rollout of its Genio sleep apnea treatment system, the medical technology company said late Wednesday.

The company completed a $95 million equity financing and expects to receive the second $15 million tranche of its European Investment Bank loan by the end of June.

Nyxoah ( NYXH ) said the funding will help accelerate the commercialization of Genio in the US, where it has built a sales force of 40 representatives following the device's US Food and Drug Administration approval in 2025.